Cafepharma Today

January 2 2025 - 10 clinical trials to watch in the first half of 2025
10 clinical trials to watch in the first half of 2025
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
Trump tariffs and drug prices
Neumora laid low by depression trial failure
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

The Medicines Company: Good for what ails you
Yahoo/SmallCapInvestor.com
Tuesday, September 23, 2008 - 7:30am
tags:
Teva Pharmaceutical to enter Japan via joint venture
Marketwatch
Tuesday, September 23, 2008 - 7:29am
tags:
Key PDL patents under fire
Bizjournals.com
Tuesday, September 23, 2008 - 7:28am
tags:
BMY Ups the Ante on ImClone
Seeking Alpha
Tuesday, September 23, 2008 - 7:24am
tags:
Credit Suisse upgrades Novartis, downgrades Sanofi-Aventis
Marketwatch
Tuesday, September 23, 2008 - 7:24am
tags:
Bristol-Myers Squibb, ImClone Systems report positive long-term Erbitux study data
Yahoo/AP
Monday, September 22, 2008 - 5:09pm
tags:
Pfizer retooling, pushing emerging market sales
Yahoo/AP
Monday, September 22, 2008 - 5:08pm
tags:
Ouch, That's Gotta Hurt! (Effexor vs. Acupuncture)
Motley Fool
Monday, September 22, 2008 - 4:33pm
tags:
CytRx closes on Innovive
Bizjournals.com
Monday, September 22, 2008 - 4:29pm
tags:
FDA Fall Decision Calendar Features Some Likely Near-Term Movers
Seeking Alpha
Monday, September 22, 2008 - 4:28pm
tags:
Why Bristol-Myers Won't Pull Its ImClone Bid
Motley Fool
Monday, September 22, 2008 - 4:27pm
tags:
Let's Bail Out Pharma Next
Motley Fool
Monday, September 22, 2008 - 4:26pm
tags:
inVentiv inTrouble?
Motley Fool
Monday, September 22, 2008 - 4:26pm
tags:
Merck Growth Outlook Flattening
Yahoo/Zacks.com
Monday, September 22, 2008 - 4:23pm
tags:
Dynavax gets $4.5 million payment
Bizjournals.com
Monday, September 22, 2008 - 4:22pm
tags:
Moody's: Pharmaceutical industry outlook is negative, especially for branded drugmakers
Yahoo/AP
Monday, September 22, 2008 - 4:21pm
tags:
Drug shares slide into red, but AstraZeneca climbs
Marketwatch
Monday, September 22, 2008 - 4:20pm
tags:
A Closer Look at La Jolla’s Riquent
Cafepharma Detailpiece
Monday, September 22, 2008 - 10:48am
tags:
Cash-poor patients cut back on meds
Fierce Pharma
Monday, September 22, 2008 - 10:47am
tags:
Novartis eyes MediGene's cancer drug - sources
Hemscott, UK
Monday, September 22, 2008 - 10:45am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline
White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels

Latest Jobs

EP Senior Mapping Specialist - Bay Area, CA
San Francisco, California, 94199
Boston Scientific Gruppe
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Sr. Training Manager, Learning & Performance
Yardley, Pennsylvania, 19067
EVERSANA
Area Manager, Immunology West Central Tulsa
Coffeyville, Kansas, 67337
CSL Behring
staff - Registered Nurse (RN) - Clinical Liaison - $80K-90K per year
Houston, Texas, 77246
AccentCare
Pharmaceutical Sales Customer Engagement - Kalamazoo, MI
Michigan, ,
Otsuka
Pharmaceutical Sales Customer Engagement - Wilmington, NC
North Carolina, ,
Otsuka
Pharmaceutical Sales Customer Engagement- Valparaiso, IN
Valparaiso, Indiana,
Otsuka
Area Manager-Specialty Northeast, Albany
Fields, Oregon, 97710
CSL Behring
Pharmaceutical Sales Customer Engagement - Atlanta S, GA
Atlanta, Georgia,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information